SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001104659-23-019450
Filing Date
2023-02-13
Accepted
2023-02-13 13:34:23
Documents
2
Group Members
ANTOINE PAPIERNIKGRAZIANO SEGHEZZIHENRIJETTE RICHTERMAINA BHAMANMONIQUE SAULNIERSOFINNOVA PARTNERS SAS

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm236517d2_sc13da.htm SC 13D/A 121403
2 EXHIBIT 99.1 tm236517d2_ex99-1.htm EX-99.1 11074
  Complete submission text file 0001104659-23-019450.txt   134192
Mailing Address C/O SOFINNOVA PARTNERS 17 RUE DE SURENE PARIS XX 75008
Business Address C/O SOFINNOVA PARTNERS 17 RUE DE SURENE PARIS XX 75008 33 1 53 054100
SOFINNOVA CAPITAL VI FCPR (Filed by) CIK: 0001441261 (see all company filings)

IRS No.: 000000000 | State of Incorp.: XX
Type: SC 13D/A

Mailing Address 430 EAST 29TH STREET 14TH FLOOR NEW YORK NY 10016
Business Address 430 EAST 29TH STREET 14TH FLOOR NEW YORK NY 10016 0114318906360
HOOKIPA Pharma Inc. (Subject) CIK: 0001760542 (see all company filings)

IRS No.: 815395687 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90985 | Film No.: 23616669
SIC: 2834 Pharmaceutical Preparations